
Neurones S.A (NRO) | Financial Analysis & Statements
Neurones S.A. | Large-cap | Technology
Neurones S.A. | Large-cap | Technology
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
810.4M
Gross Profit
506.2M
62.46%
Operating Income
78.0M
9.63%
Net Income
63.2M
7.80%
EPS (Diluted)
€2.16
Balance Sheet Metrics
Total Assets
725.7M
Total Liabilities
289.5M
Shareholders Equity
436.2M
Debt to Equity
0.66
Cash Flow Metrics
Operating Cash Flow
58.2M
Free Cash Flow
72.3M
Revenue & Profitability Trend
Neurones S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 810.4M | 741.2M | 665.4M | 579.9M | 524.5M |
Cost of Goods Sold | 304.2M | 284.5M | 256.2M | 231.3M | 212.0M |
Gross Profit | 506.2M | 456.7M | 409.2M | 348.6M | 312.4M |
Operating Expenses | 286.4M | 251.1M | 218.5M | 348.4M | 310.1M |
Operating Income | 78.0M | 75.0M | 71.9M | 61.6M | 51.1M |
Pre-tax Income | 88.1M | 80.8M | 72.9M | 61.8M | 53.6M |
Income Tax | 24.9M | 22.2M | 21.1M | 18.8M | 18.6M |
Net Income | 63.2M | 58.6M | 51.8M | 42.9M | 35.0M |
EPS (Diluted) | €2.16 | €2.03 | €1.82 | €1.56 | €1.27 |
Income Statement Trend
Neurones S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 588.1M | 545.8M | 506.6M | 464.1M | 449.1M |
Non-Current Assets | 137.6M | 130.3M | 109.6M | 103.7M | 100.8M |
Total Assets | 725.7M | 676.1M | 616.2M | 567.8M | 549.9M |
Liabilities | |||||
Current Liabilities | 252.7M | 228.9M | 207.1M | 184.6M | 161.4M |
Non-Current Liabilities | 36.9M | 37.4M | 33.5M | 30.3M | 29.4M |
Total Liabilities | 289.5M | 266.3M | 240.6M | 214.9M | 190.8M |
Equity | |||||
Total Shareholders Equity | 436.2M | 409.8M | 375.6M | 352.9M | 359.0M |
Balance Sheet Composition
Neurones S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 63.2M | 58.6M | 51.8M | 42.9M | 35.0M |
Operating Cash Flow | 58.2M | 57.9M | 54.7M | 45.0M | 35.1M |
Investing Activities | |||||
Capital Expenditures | 260.0K | 77.0K | 56.0K | 156.0K | 71.0K |
Investing Cash Flow | -7.7M | -3.6M | -1.7M | -4.0M | -820.0K |
Financing Activities | |||||
Dividends Paid | -29.1M | -26.6M | -24.2M | -48.4M | -4.8M |
Financing Cash Flow | -18.1M | -17.9M | -24.6M | -48.3M | -4.3M |
Free Cash Flow | 72.3M | 54.1M | 44.4M | 57.9M | 60.1M |
Cash Flow Trend
Neurones S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.65
Forward P/E
20.27
Price to Book
2.86
Price to Sales
1.38
PEG Ratio
20.27
Profitability Ratios
Profit Margin
6.49%
Operating Margin
10.01%
Return on Equity
14.95%
Return on Assets
6.94%
Financial Health
Current Ratio
2.33
Debt to Equity
9.63
Beta
0.58
Per Share Data
EPS (TTM)
€2.16
Book Value per Share
€15.58
Revenue per Share
€33.39
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
nro | 1.1B | 20.65 | 2.86 | 14.95% | 6.49% | 9.63 |
Financière Moncey | 2.2B | 234.00 | 1.05 | 0.47% | 68.79% | 0.00 |
Antin Infrastructure | 2.0B | 14.84 | 3.93 | 26.49% | 41.48% | 15.46 |
Peugeot Invest S.A | 1.8B | 12.33 | 0.39 | 3.70% | 58.49% | 13.41 |
M6-Metropole | 1.6B | 9.21 | 1.19 | 12.85% | 13.17% | 7.68 |
Altamir SCA | 1.0B | 56.08 | - | 1.47% | 0.00% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.